1-5 of 5
Yudi Zhang
Close
Sort by
Journal Articles

Comparison of the 2022 ICC and Who Classification Systems of Myelodysplastic Neoplasms

Junying Wu, Yudi Zhang, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Li Juan Pan, Robert Peter Gale, Bing Li, Zhijian Xiao
Journal: Blood
Blood (2023) 142 (Supplement 1): 1875.
https://doi.org/10.1182/blood-2023-184604
Published: 2023
Journal Articles

The Molecular Prognostic Scoring System for Normal Karyotype Myelodysplastic Syndromes

Wei Wang, Yudi Zhang, Wenli Yang, Yueyuan Han, Zheng Ge, Hongyan Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 4594.
https://doi.org/10.1182/blood-2023-182515
Published: 2023
Journal Articles

Validation of the 5 th Edition of the World Health Organization Classification of Myelodysplastic Neoplasms on 852 Consecutive De Novo Patients from a Single Institute

Yudi Zhang, Junying Wu, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Lijuan Pan, Bing Li, Huijun Wang, Xin Yan, Jingye Gong, Robert Peter Gale, Zhijian Xiao
Journal: Blood
Blood (2022) 140 (Supplement 1): 1343–1345.
https://doi.org/10.1182/blood-2022-160131
Published: 2022
Journal Articles

IPSS-M Is More Powerful for MDS Patients Older Than 60 Years Old

Junying Wu, Yudi Zhang, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Lijuan Pan, Bing Li, Qingyan Gao, Robert Peter Gale, Zhijian Xiao
Journal: Blood
Blood (2022) 140 (Supplement 1): 4092–4093.
https://doi.org/10.1182/blood-2022-165083
Published: 2022
Journal Articles

Unique Clinical Features and Mutation Profile in De Novo Myelodysplastic Syndromes with MF-1 and a Proposed Model for Distinguishing MDS with MF-2/3 from TN-PMF Based on Clinical and Genetic Covariates

Junying Wu, Wenjun Zhang, Peihong Zhang, Tiejun Qin, Zefeng Xu, Qi Sun, Yujiao Jia, Shiqiang Qu, Bing Li, Huijun Wang, Lijuan Pan, Jinqin Liu, Yudi Zhang, Xin Yan, Robert Peter Gale, Zhijian Xiao
Journal: Blood
Blood (2022) 140 (Supplement 1): 4058–4059.
https://doi.org/10.1182/blood-2022-163019
Published: 2022